CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

Cellares, an Integrated Development and Manufacturing Organization (IDMO), has appointed Ali Soleymannezhad as Chief ...

Circle Pharma Inc., a clinical-stage biopharmaceutical company, has appointed Anne E. Borgman, M.D., as Chief Medical Officer ...

New production facilities for PharmaGuard and a unit for the regranulation of production-related plastic waste will be built ...

Regeneron Pharmaceuticals Inc. and Tessera Therapeutics Inc. have announced a global collaboration to develop and ...

Tressler brings over 20 years of experience having served at Dynex Technologies, Senseonics, Sucampo, and MedImmune.

Over the past few years, OSD manufacturing has undergone a quiet revolution. While the dosage form itself remains unchanged, the processes, technologies, and strategies behind its production have ...

Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd.

The FDA has approved AstraZeneca’s IMFINZI combined with standard FLOT chemotherapy for adults with resectable, early-stage ...

Xmoor Pharma and Royal Free London NHS Foundation Trust have patrnered to build a seamless, scalable pathway for CGT ...

The European Commission has approved Sanofi and Regeneron’s Dupixent for the treatment of moderate-to-severe chronic spontaneous urticaria.

Marks Breyanzi’s fourth indication in Europe, adding to existing approvals for several aggressive B-cell lymphomas.